Table 3.
Hematological data of the mice administered five times oral dose of 844 mg/kg zinc oxide nanoparticles for 5 consecutive days
| Group | WBC (109/l) | RBC (1012/l) | HCT (%) | MCH (pg) | MCHC (g/dL) | PLT (109/l) | Hb (g/dL) |
|---|---|---|---|---|---|---|---|
| ZnO NPs | 8.90 ± 1.20 | 7.71 ± 0.50 | 39.93 ± 3.65 | 16.66 ± 0.31 | 32.33 ± 0.48 | 1245.00 ± 114.76 | 12.86 ± 1.0 |
| Control | 5.13 ± 1.68 | 7.45 ± 0.40 | 36.46 ± 1.32 | 16.03 ± 0.31 | 32.80 ± 0.41 | 1112.0 ± 197.4 | 11.93 ± 0.48a |
| Solvent control | 5.90 ± 2.10 | 7.94 ± 0.37 | 40.56 ± 2.01 | 16.86 ± 0.08 | 33.03 ± 0.12 | 1125.66 ± 66.49 | 13.40 ± 0.70ab |
| F2,6 | 1.360 | 0.319 | 0.662 | 2.704 | 0.419 | 0.284 | 0.956 |
| P | NS | NS | NS | NS | NS | NS | NS |
NS Non-significant (P > 0.05)